327 related articles for article (PubMed ID: 26056266)
21. H63D HFE genotype accelerates disease progression in animal models of amyotrophic lateral sclerosis.
Nandar W; Neely EB; Simmons Z; Connor JR
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2413-26. PubMed ID: 25283820
[TBL] [Abstract][Full Text] [Related]
22. Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS.
Rembach A; Turner BJ; Bruce S; Cheah IK; Scott RL; Lopes EC; Zagami CJ; Beart PM; Cheung NS; Langford SJ; Cheema SS
J Neurosci Res; 2004 Aug; 77(4):573-82. PubMed ID: 15264227
[TBL] [Abstract][Full Text] [Related]
23. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE
Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702
[TBL] [Abstract][Full Text] [Related]
24. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
[TBL] [Abstract][Full Text] [Related]
25. Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis.
Kiaei M; Kipiani K; Petri S; Choi DK; Chen J; Calingasan NY; Beal MF
J Neurochem; 2005 Apr; 93(2):403-11. PubMed ID: 15816863
[TBL] [Abstract][Full Text] [Related]
26. TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.
Cai M; Lee KW; Choi SM; Yang EJ
Neurol Res; 2015 Mar; 37(3):253-62. PubMed ID: 25213598
[TBL] [Abstract][Full Text] [Related]
27. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
Gong YH; Elliott JL
Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886
[TBL] [Abstract][Full Text] [Related]
28. L-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis.
Kira Y; Nishikawa M; Ochi A; Sato E; Inoue M
Brain Res; 2006 Jan; 1070(1):206-14. PubMed ID: 16412993
[TBL] [Abstract][Full Text] [Related]
29. Reduced VGLUT2 expression increases motor neuron viability in Sod1(G93A) mice.
Wootz H; Enjin A; Wallén-Mackenzie A; Lindholm D; Kullander K
Neurobiol Dis; 2010 Jan; 37(1):58-66. PubMed ID: 19770042
[TBL] [Abstract][Full Text] [Related]
30. Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice.
Staats KA; Van Helleputte L; Jones AR; Bento-Abreu A; Van Hoecke A; Shatunov A; Simpson CL; Lemmens R; Jaspers T; Fukami K; Nakamura Y; Brown RH; Van Damme P; Liston A; Robberecht W; Al-Chalabi A; Van Den Bosch L
Neurobiol Dis; 2013 Dec; 60():11-7. PubMed ID: 23969236
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
[TBL] [Abstract][Full Text] [Related]
32. Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis.
Garbuzova-Davis S; Willing AE; Milliken M; Saporta S; Zigova T; Cahill DW; Sanberg PR
Exp Neurol; 2002 Apr; 174(2):169-80. PubMed ID: 11922659
[TBL] [Abstract][Full Text] [Related]
33. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
[TBL] [Abstract][Full Text] [Related]
34. Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice.
Zhao CP; Zhang C; Zhou SN; Xie YM; Wang YH; Huang H; Shang YC; Li WY; Zhou C; Yu MJ; Feng SW
Cytotherapy; 2007; 9(5):414-26. PubMed ID: 17786603
[TBL] [Abstract][Full Text] [Related]
35. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
Kim J; Kim TY; Cho KS; Kim HN; Koh JY
Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
[TBL] [Abstract][Full Text] [Related]
36. The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis.
Liang X; Wang Q; Shi J; Lokteva L; Breyer RM; Montine TJ; Andreasson K
Ann Neurol; 2008 Sep; 64(3):304-14. PubMed ID: 18825663
[TBL] [Abstract][Full Text] [Related]
37. Dysequilibrium between caspases and their inhibitors in a mouse model for amyotrophic lateral sclerosis.
Tokuda E; Ono S; Ishige K; Watanabe S; Okawa E; Ito Y; Suzuki T
Brain Res; 2007 May; 1148():234-42. PubMed ID: 17397813
[TBL] [Abstract][Full Text] [Related]
38. A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis.
Pompl PN; Ho L; Bianchi M; McManus T; Qin W; Pasinetti GM
FASEB J; 2003 Apr; 17(6):725-7. PubMed ID: 12586733
[TBL] [Abstract][Full Text] [Related]
39. Experimental transmissibility of mutant SOD1 motor neuron disease.
Ayers JI; Fromholt S; Koch M; DeBosier A; McMahon B; Xu G; Borchelt DR
Acta Neuropathol; 2014 Dec; 128(6):791-803. PubMed ID: 25262000
[TBL] [Abstract][Full Text] [Related]
40. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
